Latest filing published 28 Nov 2017 for Pacific Biosciences of California, INC., €423.
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +37.1%Entry US$6.36 · Close at T+365 US$8.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kevin P. Corcoran: trading record in brief
Kevin P. Corcoran discloses dealings in Pacific Biosciences of California, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 2 March 2015 and the latest from 24 November 2017.
Purchases make up the whole of the open-market record (1 purchase, €12k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 option exercises.
Most recently, on 28 November 2017, the filings show an option exercise worth €423 in Pacific Biosciences of California, Inc. The last purchase on record was published on 2 March 2015, which is 4,269 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kevin P. Corcoran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 256 shares@ US$1.960.2% of flowCommon StockSEC:0001209191-17-062664:0
- 28,061 shares@ US$1.9624.3% of flowCommon StockSEC:0001209191-17-045937:0
- 84,183 shares@ US$1.9675.5% of flowCommon StockSEC:0001209191-17-040099:0
- 2,816 shares@ US$4.91Common StockSEC:0001299130-15-000024:0Canonical exit: 31 May 2015 (T+90)
4 of 4 declarations
